LD-2 disclosure · 3rd Quarter - Report
HALEON US HOLDINGS LLC
Client
- Description
- consumer health care company
- Location
- New Jersey · United States of America
Registrant
- Description
- lobbying firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use; H.R.4273/S.2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R.5371, Continuing Appropriations and Extensions Act, 2026.
LobbyistsMATHEW LAPINSKI · JASON BENJAMIN VAN PELT · BRITTANY JOHNSON HERNANDEZ · ms CHERYL LYNN JAEGER · LUCIA PANZA · mr REGINALD ALEXANDER MCCRIMMON · mr STEPHEN THOMAS VOLJAVEC
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Issues related to coverage of over-the-counter products with FSAs and HSAs.
LobbyistsMATHEW LAPINSKI · JASON BENJAMIN VAN PELT · BRITTANY JOHNSON HERNANDEZ · ms CHERYL LYNN JAEGER · LUCIA PANZA · mr REGINALD ALEXANDER MCCRIMMON · mr STEPHEN THOMAS VOLJAVEC
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
Policies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166).